Viatris Inc. closed 32.69% below its 52-week high of $13.55, which the company achieved on November 25th.

This was the stock's second consecutive day of losses.

Viatris has picked a prominent spot to voice its view that “access to healthcare matters to everyone, everywhere,” slapping a video that conveys the message on the seven-stories-tall Nasdaq ...

Consumer Medicine Information (CMI) about Dexamethasone Viatris intended for persons living in Australia.

Within the last quarter, Viatris (NASDAQ:VTRS) has observed the following analyst ratings: These 4 analysts have an average price target of $12.25 versus the current price of Viatris at $11.29 ...

Viatris Inc (Symbol: VTRS) presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

Consumer Medicine Information (CMI) about Metoprolol IV Viatris intended for persons living in Australia.

Analysts have provided the following ratings for Viatris (NASDAQ:VTRS) within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Viatris. The company has an ...

Viatris VTRS, a global healthcare company, is scheduled to report first-quarter 2021 results on May 10. The company was formed in November 2020 through the combination of Mylan and Upjohn.

Yes, U.S. RC-135s Have Used Bogus Hex Codes To Transmit A False Identity. But It’s Not To Fool China Or Other Enemies.

Their merger isn't official yet, but a new logo is ready to go. Mylan and Pfizer's Upjohn unit unveiled new branding for the to-be-combined company, dubbed Viatris, on Thursday with a tri-color ...